Glenmark Pharmaceuticals Ltd - 532296 - Update On The Company''s Monroe, North Carolina (USA) Facility

Glenmark Pharmaceuticals Ltd.

NSE: GLENMARK | BSE: 532296 | ISIN: INE935A01035 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive

1955.5000 11.50 (0.59%)

NSE Nov 28, 2025 11:32 AM

53.31% Gain from 52W Low

Volume: 272.6K

Glenmark Pharmaceuticals Ltd.

27 Nov 2025, 10:15AM

1955.50

0.59%

Company Update

Glenmark Pharmaceuticals Ltd - 532296 - Update On The Company''s Monroe, North Carolina (USA) Facility

BSE India

Update on the Company''s Monroe, North Carolina (USA) Facility

More from Glenmark Pharmaceuticals Ltd.

Recommended

Market trades higher, Sudeep Pharma debuts at a 23.1% premium

Trendlyne Marketwatch | 28 Nov 2025, 11:22AM

Gold, solar, and finance stocks fuel India’s Q2 earnings jump

The Baseline | 27 Nov 2025, 03:15PM

Earnings Call Transcript - Q4FY20 for Glenmark Pharmaceuticals